| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.61e-10 | 188 | 30 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.13e-06 | 891 | 30 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 6.54e-06 | 3 | 30 | 2 | GO:0005010 | |
| GeneOntologyMolecularFunction | growth factor binding | 8.38e-05 | 156 | 30 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.26e-04 | 65 | 30 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.43e-04 | 12 | 30 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.78e-04 | 85 | 30 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 4.95e-04 | 22 | 30 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | calcium ion binding | 7.50e-04 | 749 | 30 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.32e-03 | 145 | 30 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.17e-03 | 46 | 30 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | integrin binding | 2.26e-03 | 175 | 30 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | protease binding | 2.48e-03 | 181 | 30 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.22e-03 | 72 | 30 | 2 | GO:0015026 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.33e-05 | 566 | 30 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.38e-05 | 802 | 30 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.47e-05 | 377 | 30 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.49e-05 | 378 | 30 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.51e-05 | 379 | 30 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.61e-05 | 819 | 30 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.71e-05 | 826 | 30 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.10e-05 | 850 | 30 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.76e-05 | 883 | 30 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | axon development | 2.99e-05 | 642 | 30 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.17e-05 | 1186 | 30 | 9 | GO:0007167 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 3.29e-05 | 43 | 30 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 3.35e-05 | 1194 | 30 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 3.75e-05 | 131 | 30 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.22e-05 | 285 | 30 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.31e-05 | 286 | 30 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 7.87e-05 | 748 | 30 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | response to vitamin E | 1.12e-04 | 11 | 30 | 2 | GO:0033197 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.12e-04 | 11 | 30 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 1.31e-04 | 68 | 30 | 3 | GO:0007528 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.45e-04 | 1442 | 30 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta1 production | 1.58e-04 | 13 | 30 | 2 | GO:0032905 | |
| GeneOntologyBiologicalProcess | cellular response to insulin-like growth factor stimulus | 1.58e-04 | 13 | 30 | 2 | GO:1990314 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.82e-04 | 76 | 30 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.82e-04 | 197 | 30 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | kidney development | 1.83e-04 | 372 | 30 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.84e-04 | 14 | 30 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 2.12e-04 | 80 | 30 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | renal system development | 2.17e-04 | 386 | 30 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.44e-04 | 84 | 30 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.54e-04 | 215 | 30 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.54e-04 | 215 | 30 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | blood vessel development | 3.01e-04 | 929 | 30 | 7 | GO:0001568 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 3.18e-04 | 228 | 30 | 4 | GO:0001101 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.20e-04 | 92 | 30 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 3.20e-04 | 92 | 30 | 3 | GO:0051057 | |
| GeneOntologyBiologicalProcess | metanephros development | 3.51e-04 | 95 | 30 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | neuron projection development | 3.78e-04 | 1285 | 30 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | estrous cycle | 3.82e-04 | 20 | 30 | 2 | GO:0044849 | |
| GeneOntologyBiologicalProcess | vasculature development | 3.89e-04 | 969 | 30 | 7 | GO:0001944 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.17e-04 | 445 | 30 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | response to axon injury | 4.71e-04 | 105 | 30 | 3 | GO:0048678 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 4.84e-04 | 106 | 30 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 5.08e-04 | 23 | 30 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 5.08e-04 | 23 | 30 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 6.00e-04 | 482 | 30 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | tube development | 6.78e-04 | 1402 | 30 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 7.55e-04 | 28 | 30 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 7.65e-04 | 124 | 30 | 3 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron development | 8.98e-04 | 1463 | 30 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | artery development | 9.37e-04 | 133 | 30 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 9.96e-04 | 817 | 30 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 1.23e-03 | 327 | 30 | 4 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.26e-03 | 329 | 30 | 4 | GO:0018212 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 1.33e-03 | 150 | 30 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.36e-03 | 336 | 30 | 4 | GO:0071560 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.42e-03 | 875 | 30 | 6 | GO:0045596 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.46e-03 | 343 | 30 | 4 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.53e-03 | 347 | 30 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.54e-03 | 40 | 30 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta production | 1.54e-03 | 40 | 30 | 2 | GO:0071604 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 1.62e-03 | 41 | 30 | 2 | GO:0035025 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.62e-03 | 41 | 30 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.91e-03 | 927 | 30 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.91e-03 | 1269 | 30 | 7 | GO:0009887 | |
| GeneOntologyBiologicalProcess | nephron development | 2.03e-03 | 174 | 30 | 3 | GO:0072006 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 2.12e-03 | 47 | 30 | 2 | GO:0014044 | |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 2.30e-03 | 49 | 30 | 2 | GO:0071364 | |
| GeneOntologyBiologicalProcess | response to angiotensin | 2.40e-03 | 50 | 30 | 2 | GO:1990776 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic nuclear division | 2.40e-03 | 50 | 30 | 2 | GO:0045840 | |
| GeneOntologyBiologicalProcess | response to wounding | 2.41e-03 | 659 | 30 | 5 | GO:0009611 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 2.68e-03 | 405 | 30 | 4 | GO:0042742 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 2.79e-03 | 54 | 30 | 2 | GO:0070849 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.85e-03 | 412 | 30 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 2.89e-03 | 55 | 30 | 2 | GO:0014037 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 2.96e-03 | 199 | 30 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | response to amino acid | 3.09e-03 | 202 | 30 | 3 | GO:0043200 | |
| GeneOntologyBiologicalProcess | exocrine system development | 3.11e-03 | 57 | 30 | 2 | GO:0035272 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 3.32e-03 | 59 | 30 | 2 | GO:0085029 | |
| GeneOntologyBiologicalProcess | insulin-like growth factor receptor signaling pathway | 3.43e-03 | 60 | 30 | 2 | GO:0048009 | |
| GeneOntologyCellularComponent | laminin-3 complex | 2.67e-09 | 3 | 30 | 3 | GO:0005608 | |
| GeneOntologyCellularComponent | laminin complex | 3.18e-07 | 10 | 30 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.82e-07 | 12 | 30 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.82e-07 | 12 | 30 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.86e-06 | 656 | 30 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.93e-06 | 658 | 30 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.49e-06 | 21 | 30 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.94e-06 | 530 | 30 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 2.69e-05 | 122 | 30 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.67e-04 | 17 | 30 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | collagen trimer | 2.70e-04 | 88 | 30 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.05e-04 | 109 | 30 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.47e-04 | 112 | 30 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.24e-03 | 332 | 30 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | receptor complex | 1.31e-03 | 581 | 30 | 5 | GO:0043235 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.24e-03 | 59 | 30 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 8.35e-03 | 96 | 30 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | ciliary membrane | 8.69e-03 | 98 | 30 | 2 | GO:0060170 | |
| HumanPheno | Cervical insufficiency | 4.84e-05 | 4 | 15 | 2 | HP:0030009 | |
| HumanPheno | Incisional hernia | 4.84e-05 | 4 | 15 | 2 | HP:0004872 | |
| HumanPheno | Atypical scarring of skin | 4.96e-05 | 74 | 15 | 4 | HP:0000987 | |
| HumanPheno | Hypoplasia of the iris | 1.28e-04 | 35 | 15 | 3 | HP:0007676 | |
| HumanPheno | Subcutaneous nodule | 1.32e-04 | 95 | 15 | 4 | HP:0001482 | |
| HumanPheno | Abnormal pleura morphology | 1.41e-04 | 187 | 15 | 5 | HP:0002103 | |
| HumanPheno | Atrophic scars | 1.51e-04 | 37 | 15 | 3 | HP:0001075 | |
| HumanPheno | Fragile skin | 1.51e-04 | 37 | 15 | 3 | HP:0001030 | |
| HumanPheno | Molluscoid pseudotumors | 1.69e-04 | 7 | 15 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 1.69e-04 | 7 | 15 | 2 | HP:0000139 | |
| HumanPheno | Scarring | 1.75e-04 | 102 | 15 | 4 | HP:0100699 | |
| HumanPheno | Dermal atrophy | 2.10e-04 | 107 | 15 | 4 | HP:0004334 | |
| HumanPheno | Genital hernia | 2.24e-04 | 8 | 15 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 2.24e-04 | 8 | 15 | 2 | HP:0025019 | |
| HumanPheno | Papule | 2.38e-04 | 209 | 15 | 5 | HP:0200034 | |
| HumanPheno | Internal hemorrhage | 2.49e-04 | 339 | 15 | 6 | HP:0011029 | |
| HumanPheno | Abnormality of blood circulation | 2.62e-04 | 498 | 15 | 7 | HP:0011028 | |
| HumanPheno | Abnormal vascular physiology | 2.87e-04 | 348 | 15 | 6 | HP:0030163 | |
| HumanPheno | Premature osteoarthritis | 3.59e-04 | 10 | 15 | 2 | HP:0003088 | |
| HumanPheno | Cigarette-paper scars | 3.59e-04 | 10 | 15 | 2 | HP:0001073 | |
| HumanPheno | Dilatation of the cerebral artery | 3.95e-04 | 51 | 15 | 3 | HP:0004944 | |
| HumanPheno | Finger joint hypermobility | 4.19e-04 | 52 | 15 | 3 | HP:0006094 | |
| HumanPheno | Abnormal bleeding | 4.20e-04 | 537 | 15 | 7 | HP:0001892 | |
| HumanPheno | Cranial hyperostosis | 4.43e-04 | 53 | 15 | 3 | HP:0004437 | |
| HumanPheno | Skin nodule | 4.71e-04 | 132 | 15 | 4 | HP:0200036 | |
| HumanPheno | Skin ulcer | 4.99e-04 | 134 | 15 | 4 | HP:0200042 | |
| HumanPheno | Arterial dissection | 5.25e-04 | 12 | 15 | 2 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 5.25e-04 | 12 | 15 | 2 | HP:0004947 | |
| HumanPheno | Encephalomalacia | 5.25e-04 | 12 | 15 | 2 | HP:0040197 | |
| HumanPheno | Abnormality of hand joint mobility | 5.50e-04 | 57 | 15 | 3 | HP:0006256 | |
| HumanPheno | Arthritis | 5.58e-04 | 251 | 15 | 5 | HP:0001369 | |
| HumanPheno | Increased skull ossification | 5.78e-04 | 58 | 15 | 3 | HP:0004330 | |
| HumanPheno | Protrusio acetabuli | 6.20e-04 | 13 | 15 | 2 | HP:0003179 | |
| HumanPheno | Abnormal uterine cervix morphology | 6.20e-04 | 13 | 15 | 2 | HP:0012888 | |
| HumanPheno | Rieger anomaly | 6.20e-04 | 13 | 15 | 2 | HP:0000558 | |
| HumanPheno | Ectopic calcification | 6.33e-04 | 258 | 15 | 5 | HP:0010766 | |
| HumanPheno | Hyperostosis | 6.71e-04 | 61 | 15 | 3 | HP:0100774 | |
| HumanPheno | Transient ischemic attack | 6.71e-04 | 61 | 15 | 3 | HP:0002326 | |
| HumanPheno | Tricuspid valve prolapse | 7.22e-04 | 14 | 15 | 2 | HP:0001704 | |
| HumanPheno | Pulmonary artery dilatation | 7.22e-04 | 14 | 15 | 2 | HP:0004927 | |
| HumanPheno | Osteoarthritis | 8.09e-04 | 65 | 15 | 3 | HP:0002758 | |
| HumanPheno | Decreased size of nerve terminals | 8.31e-04 | 15 | 15 | 2 | HP:0003443 | |
| HumanPheno | High, narrow palate | 8.87e-04 | 156 | 15 | 4 | HP:0002705 | |
| HumanPheno | Small joint hypermobilty | 9.63e-04 | 69 | 15 | 3 | HP:0430046 | |
| HumanPheno | Anterior bulging of the globe | 9.67e-04 | 283 | 15 | 5 | HP:0000644 | |
| HumanPheno | Proptosis | 9.67e-04 | 283 | 15 | 5 | HP:0000520 | |
| HumanPheno | Aortic root aneurysm | 1.00e-03 | 70 | 15 | 3 | HP:0002616 | |
| HumanPheno | Abnormal pulmonary valve physiology | 1.05e-03 | 163 | 15 | 4 | HP:0031654 | |
| HumanPheno | Platybasia | 1.07e-03 | 17 | 15 | 2 | HP:0002691 | |
| HumanPheno | Premature rupture of membranes | 1.07e-03 | 17 | 15 | 2 | HP:0001788 | |
| HumanPheno | Aortic dilatation | 1.17e-03 | 168 | 15 | 4 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 1.17e-03 | 168 | 15 | 4 | HP:0004942 | |
| HumanPheno | Abnormality of lens shape | 1.21e-03 | 18 | 15 | 2 | HP:0011526 | |
| HumanPheno | Abnormal cerebral artery morphology | 1.25e-03 | 171 | 15 | 4 | HP:0009145 | |
| HumanPheno | Abnormality of coagulation | 1.32e-03 | 647 | 15 | 7 | HP:0001928 | |
| HumanPheno | Pneumothorax | 1.33e-03 | 77 | 15 | 3 | HP:0002107 | |
| HumanPheno | Narrow nasal ridge | 1.34e-03 | 19 | 15 | 2 | HP:0000418 | |
| HumanPheno | Bruising susceptibility | 1.45e-03 | 178 | 15 | 4 | HP:0000978 | |
| HumanPheno | Abnormal arterial physiology | 1.55e-03 | 181 | 15 | 4 | HP:0025323 | |
| HumanPheno | Descending aortic dissection | 1.65e-03 | 21 | 15 | 2 | HP:0012499 | |
| HumanPheno | Maculopapular exanthema | 1.65e-03 | 21 | 15 | 2 | HP:0040186 | |
| HumanPheno | Intestinal obstruction | 1.65e-03 | 83 | 15 | 3 | HP:0005214 | |
| HumanPheno | Smooth philtrum | 1.68e-03 | 185 | 15 | 4 | HP:0000319 | |
| HumanPheno | Dilatation of the ascending aorta | 1.71e-03 | 84 | 15 | 3 | HP:0005111 | |
| HumanPheno | Elbow dislocation | 1.71e-03 | 84 | 15 | 3 | HP:0003042 | |
| HumanPheno | Pectus excavatum | 1.76e-03 | 323 | 15 | 5 | HP:0000767 | |
| HumanPheno | Exanthem | 1.81e-03 | 22 | 15 | 2 | HP:4000054 | |
| HumanPheno | Chondrocalcinosis | 1.81e-03 | 22 | 15 | 2 | HP:0000934 | |
| HumanPheno | Abnormality of subcutaneous fat tissue | 1.83e-03 | 86 | 15 | 3 | HP:0001001 | |
| HumanPheno | Abnormal knee physiology | 1.89e-03 | 87 | 15 | 3 | HP:0034670 | |
| HumanPheno | Abnormal cortical bone morphology | 2.08e-03 | 90 | 15 | 3 | HP:0003103 | |
| HumanPheno | Dural ectasia | 2.15e-03 | 24 | 15 | 2 | HP:0100775 | |
| HumanPheno | Abnormal pulmonary valve morphology | 2.16e-03 | 198 | 15 | 4 | HP:0001641 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 2.28e-03 | 201 | 15 | 4 | HP:0008065 | |
| HumanPheno | Gastrointestinal obstruction | 2.29e-03 | 93 | 15 | 3 | HP:0004796 | |
| HumanPheno | Narrow palate | 2.32e-03 | 202 | 15 | 4 | HP:0000189 | |
| HumanPheno | Abnormality of the middle ear ossicles | 2.34e-03 | 25 | 15 | 2 | HP:0004452 | |
| HumanPheno | Biconcave vertebral bodies | 2.34e-03 | 25 | 15 | 2 | HP:0004586 | |
| HumanPheno | Abnormal spinal meningeal morphology | 2.34e-03 | 25 | 15 | 2 | HP:0010303 | |
| HumanPheno | Abnormality of skull ossification | 2.36e-03 | 94 | 15 | 3 | HP:0002703 | |
| HumanPheno | Convex nasal ridge | 2.43e-03 | 95 | 15 | 3 | HP:0000444 | |
| HumanPheno | Upper extremity joint dislocation | 2.50e-03 | 96 | 15 | 3 | HP:0030310 | |
| HumanPheno | Ascending aortic dissection | 2.53e-03 | 26 | 15 | 2 | HP:0004933 | |
| HumanPheno | Abnormality of pulmonary circulation | 2.58e-03 | 208 | 15 | 4 | HP:0030875 | |
| HumanPheno | Dermal translucency | 2.72e-03 | 27 | 15 | 2 | HP:0010648 | |
| HumanPheno | Abnormal ascending aorta morphology | 2.72e-03 | 27 | 15 | 2 | HP:0031784 | |
| HumanPheno | Vascular dilatation | 2.92e-03 | 215 | 15 | 4 | HP:0002617 | |
| MousePheno | aortic dissection | 4.76e-07 | 9 | 26 | 3 | MP:0004044 | |
| MousePheno | abnormal osteocyte morphology | 2.56e-06 | 15 | 26 | 3 | MP:0008753 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 4.58e-06 | 18 | 26 | 3 | MP:0030485 | |
| MousePheno | thick dermal layer | 8.59e-06 | 22 | 26 | 3 | MP:0001245 | |
| MousePheno | abnormal aorta elastic tissue morphology | 8.59e-06 | 22 | 26 | 3 | MP:0009862 | |
| MousePheno | abnormal inflammatory response | MEP1A COL3A1 LAMA3 UMOD LAMB2 HABP2 FBN1 TNFRSF1A LUM CRIM1 COL1A1 | 9.62e-06 | 1310 | 26 | 11 | MP:0001845 |
| MousePheno | abnormal blood vessel elastic tissue morphology | 1.13e-05 | 24 | 26 | 3 | MP:0006083 | |
| MousePheno | increased inflammatory response | MEP1A COL3A1 LAMA3 UMOD LAMB2 HABP2 FBN1 TNFRSF1A CRIM1 COL1A1 | 1.20e-05 | 1077 | 26 | 10 | MP:0001846 |
| MousePheno | abnormal cutaneous collagen fibril morphology | 1.62e-05 | 27 | 26 | 3 | MP:0008438 | |
| MousePheno | abnormal glomerular filtration barrier function | 1.99e-05 | 4 | 26 | 2 | MP:0011856 | |
| MousePheno | abnormal renal glomerular filtration | 2.02e-05 | 29 | 26 | 3 | MP:0013284 | |
| MousePheno | abnormal tendon morphology | 2.48e-05 | 31 | 26 | 3 | MP:0005503 | |
| MousePheno | abnormal skin tensile strength | 2.73e-05 | 32 | 26 | 3 | MP:0005275 | |
| MousePheno | abnormal dermal layer morphology | 4.42e-05 | 108 | 26 | 4 | MP:0001243 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 4.97e-05 | 6 | 26 | 2 | MP:0001055 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 4.97e-05 | 6 | 26 | 2 | MP:0001054 | |
| MousePheno | abnormal aorta tunica media morphology | 4.99e-05 | 39 | 26 | 3 | MP:0009873 | |
| MousePheno | abnormal retina blood vessel morphology | 6.22e-05 | 234 | 26 | 5 | MP:0010097 | |
| MousePheno | abnormal compact bone thickness | 7.12e-05 | 122 | 26 | 4 | MP:0000134 | |
| MousePheno | abnormal respiration | 8.17e-05 | 598 | 26 | 7 | MP:0001943 | |
| MousePheno | thick neurocranium | 9.25e-05 | 8 | 26 | 2 | MP:0030278 | |
| MousePheno | abnormal retina inner limiting membrane morphology | 9.25e-05 | 8 | 26 | 2 | MP:0010235 | |
| MousePheno | abnormal bone trabecula morphology | 1.02e-04 | 134 | 26 | 4 | MP:0010867 | |
| MousePheno | abnormal aorta wall morphology | 1.06e-04 | 50 | 26 | 3 | MP:0009866 | |
| MousePheno | abnormal aorta tunica adventitia morphology | 1.19e-04 | 9 | 26 | 2 | MP:0009871 | |
| MousePheno | abnormal renal filtration | 1.33e-04 | 54 | 26 | 3 | MP:0013285 | |
| MousePheno | renal interstitial fibrosis | 1.33e-04 | 54 | 26 | 3 | MP:0003215 | |
| MousePheno | abnormal skin morphology | COL3A1 LAMA3 PRR9 IGF1R FBN1 TNFRSF1A LUM CRIM1 MOV10 COL1A1 | 1.60e-04 | 1455 | 26 | 10 | MP:0002060 |
| MousePheno | abnormal skin physiology | 1.65e-04 | 288 | 26 | 5 | MP:0005501 | |
| MousePheno | abnormal blood vessel morphology | COL3A1 ERBB2 FBN1 CRIM1 PRICKLE3 NOTCH3 MOV10 NOTCH4 LAMA1 COL1A1 | 1.77e-04 | 1472 | 26 | 10 | MP:0001614 |
| MousePheno | abnormal skin appearance | 1.88e-04 | 473 | 26 | 6 | MP:0009931 | |
| MousePheno | abnormal tooth hard tissue morphology | 2.11e-04 | 63 | 26 | 3 | MP:0003930 | |
| MousePheno | abnormal kidney interstitium morphology | 2.53e-04 | 67 | 26 | 3 | MP:0011425 | |
| MousePheno | decreased respiration | 2.56e-04 | 170 | 26 | 4 | MP:0014274 | |
| MousePheno | skin fibrosis | 2.56e-04 | 13 | 26 | 2 | MP:0009932 | |
| MousePheno | abnormal compact bone morphology | 2.68e-04 | 172 | 26 | 4 | MP:0003797 | |
| MousePheno | abnormal bone volume | 2.74e-04 | 173 | 26 | 4 | MP:0010874 | |
| MousePheno | decreased bone trabecula number | 2.88e-04 | 70 | 26 | 3 | MP:0010869 | |
| MousePheno | tight skin | 2.99e-04 | 14 | 26 | 2 | MP:0001198 | |
| MousePheno | renal/urinary system inflammation | 3.18e-04 | 180 | 26 | 4 | MP:0011762 | |
| MousePheno | decreased renal glomerular filtration rate | 3.44e-04 | 15 | 26 | 2 | MP:0005528 | |
| MousePheno | lung inflammation | 3.53e-04 | 185 | 26 | 4 | MP:0001861 | |
| MousePheno | abnormal glial cell morphology | 3.82e-04 | 345 | 26 | 5 | MP:0003634 | |
| MousePheno | abnormal collagen level | 3.93e-04 | 16 | 26 | 2 | MP:0020252 | |
| MousePheno | renal fibrosis | 3.96e-04 | 78 | 26 | 3 | MP:0003985 | |
| MousePheno | decreased compact bone thickness | 4.76e-04 | 83 | 26 | 3 | MP:0000135 | |
| MousePheno | decreased percent body fat/body weight | 4.93e-04 | 84 | 26 | 3 | MP:0005459 | |
| MousePheno | abnormal kidney papilla morphology | 5.00e-04 | 18 | 26 | 2 | MP:0004193 | |
| MousePheno | abnormal kidney pyramid morphology | 5.58e-04 | 19 | 26 | 2 | MP:0004192 | |
| MousePheno | abnormal Muller cell morphology | 6.19e-04 | 20 | 26 | 2 | MP:0005547 | |
| MousePheno | syndactyly | 6.63e-04 | 93 | 26 | 3 | MP:0000564 | |
| MousePheno | abnormal retina vasculature morphology | 6.68e-04 | 390 | 26 | 5 | MP:0002792 | |
| MousePheno | respiratory system inflammation | 6.80e-04 | 220 | 26 | 4 | MP:0002405 | |
| MousePheno | renal glomerulus cyst | 6.84e-04 | 21 | 26 | 2 | MP:0011682 | |
| MousePheno | renal tubular necrosis | 6.84e-04 | 21 | 26 | 2 | MP:0004154 | |
| MousePheno | abnormal aorta morphology | 7.40e-04 | 225 | 26 | 4 | MP:0000272 | |
| MousePheno | abnormal renal tubule morphology | 7.64e-04 | 227 | 26 | 4 | MP:0002703 | |
| MousePheno | decreased bone volume | 8.19e-04 | 100 | 26 | 3 | MP:0010876 | |
| MousePheno | abnormal eye vasculature morphology | 8.84e-04 | 415 | 26 | 5 | MP:0031346 | |
| MousePheno | decreased bone trabecular spacing | 8.95e-04 | 24 | 26 | 2 | MP:0013631 | |
| MousePheno | hematoma | 8.95e-04 | 24 | 26 | 2 | MP:0008817 | |
| MousePheno | abnormal response/metabolism to endogenous compounds | 9.18e-04 | 104 | 26 | 3 | MP:0003638 | |
| MousePheno | abnormal phrenic nerve morphology | 9.72e-04 | 25 | 26 | 2 | MP:0001078 | |
| MousePheno | abnormal renal glomerular filtration rate | 9.72e-04 | 25 | 26 | 2 | MP:0002847 | |
| MousePheno | abnormal respiratory system physiology | 9.79e-04 | 897 | 26 | 7 | MP:0002133 | |
| MousePheno | abnormal renal glomerular capsule morphology | 9.97e-04 | 107 | 26 | 3 | MP:0002828 | |
| MousePheno | abnormal tooth development | 1.02e-03 | 108 | 26 | 3 | MP:0000116 | |
| MousePheno | decreased skin tensile strength | 1.05e-03 | 26 | 26 | 2 | MP:0003089 | |
| MousePheno | abnormal trabecular bone connectivity density | 1.13e-03 | 27 | 26 | 2 | MP:0010931 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 1.13e-03 | 27 | 26 | 2 | MP:0011409 | |
| MousePheno | abnormal artery morphology | 1.15e-03 | 440 | 26 | 5 | MP:0002191 | |
| MousePheno | abnormal trabecular bone volume | 1.17e-03 | 113 | 26 | 3 | MP:0010877 | |
| MousePheno | abnormal renal filtration rate | 1.22e-03 | 28 | 26 | 2 | MP:0005556 | |
| MousePheno | abnormal endoplasmic reticulum morphology | 1.22e-03 | 28 | 26 | 2 | MP:0009378 | |
| MousePheno | renal necrosis | 1.40e-03 | 30 | 26 | 2 | MP:0003946 | |
| MousePheno | abnormal CNS glial cell morphology | 1.50e-03 | 272 | 26 | 4 | MP:0000952 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 1.50e-03 | 31 | 26 | 2 | MP:0011349 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.59e-03 | 1269 | 26 | 8 | MP:0011111 | |
| MousePheno | increased bone ossification | 1.59e-03 | 32 | 26 | 2 | MP:0020039 | |
| MousePheno | decreased total body fat amount | 1.61e-03 | 475 | 26 | 5 | MP:0010025 | |
| MousePheno | abnormal trabecular bone morphology | 1.87e-03 | 289 | 26 | 4 | MP:0000130 | |
| Domain | Growth_fac_rcpt_ | LAMA3 LRP4 UMOD LAMB2 ERBB2 IGF1R FBN1 CRIM1 NOTCH3 NOTCH4 LAMA1 | 4.60e-16 | 156 | 30 | 11 | IPR009030 |
| Domain | EGF | 1.98e-12 | 235 | 30 | 10 | SM00181 | |
| Domain | EGF-like_dom | 3.52e-12 | 249 | 30 | 10 | IPR000742 | |
| Domain | EGF_1 | 4.46e-12 | 255 | 30 | 10 | PS00022 | |
| Domain | EGF-like_CS | 5.62e-12 | 261 | 30 | 10 | IPR013032 | |
| Domain | EGF_2 | 6.53e-12 | 265 | 30 | 10 | PS01186 | |
| Domain | VWF_dom | 5.08e-11 | 42 | 30 | 6 | IPR001007 | |
| Domain | VWFC_1 | 2.74e-09 | 36 | 30 | 5 | PS01208 | |
| Domain | VWC | 3.64e-09 | 38 | 30 | 5 | SM00214 | |
| Domain | VWFC_2 | 3.64e-09 | 38 | 30 | 5 | PS50184 | |
| Domain | EGF_CA | 3.58e-08 | 122 | 30 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.95e-08 | 124 | 30 | 6 | IPR001881 | |
| Domain | EGF | 4.35e-08 | 126 | 30 | 6 | PF00008 | |
| Domain | EGF_3 | 7.26e-08 | 235 | 30 | 7 | PS50026 | |
| Domain | VWC | 1.08e-07 | 28 | 30 | 4 | PF00093 | |
| Domain | EGF_CA | 2.40e-07 | 86 | 30 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 4.38e-07 | 97 | 30 | 5 | IPR018097 | |
| Domain | EGF_CA | 4.85e-07 | 99 | 30 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.10e-07 | 100 | 30 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.82e-07 | 106 | 30 | 5 | IPR000152 | |
| Domain | LAMININ_NTER | 2.06e-06 | 16 | 30 | 3 | PS51117 | |
| Domain | Laminin_N | 2.06e-06 | 16 | 30 | 3 | PF00055 | |
| Domain | Laminin_N | 2.06e-06 | 16 | 30 | 3 | IPR008211 | |
| Domain | LamNT | 2.06e-06 | 16 | 30 | 3 | SM00136 | |
| Domain | VWC_out | 3.56e-06 | 19 | 30 | 3 | SM00215 | |
| Domain | EGF_LAM_2 | 1.47e-05 | 30 | 30 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.47e-05 | 30 | 30 | 3 | PS01248 | |
| Domain | NOD | 1.49e-05 | 4 | 30 | 2 | PF06816 | |
| Domain | Notch | 1.49e-05 | 4 | 30 | 2 | IPR008297 | |
| Domain | NODP | 1.49e-05 | 4 | 30 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.49e-05 | 4 | 30 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.49e-05 | 4 | 30 | 2 | IPR010660 | |
| Domain | NOD | 1.49e-05 | 4 | 30 | 2 | SM01338 | |
| Domain | NODP | 1.49e-05 | 4 | 30 | 2 | SM01339 | |
| Domain | Laminin_EGF | 2.36e-05 | 35 | 30 | 3 | PF00053 | |
| Domain | EGF_Lam | 2.36e-05 | 35 | 30 | 3 | SM00180 | |
| Domain | LNR | 2.49e-05 | 5 | 30 | 2 | PS50258 | |
| Domain | Laminin_aI | 2.49e-05 | 5 | 30 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.49e-05 | 5 | 30 | 2 | PF06008 | |
| Domain | Laminin_II | 2.49e-05 | 5 | 30 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.49e-05 | 5 | 30 | 2 | IPR010307 | |
| Domain | Laminin_EGF | 3.04e-05 | 38 | 30 | 3 | IPR002049 | |
| Domain | Notch_dom | 5.21e-05 | 7 | 30 | 2 | IPR000800 | |
| Domain | Furin-like | 5.21e-05 | 7 | 30 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 5.21e-05 | 7 | 30 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 5.21e-05 | 7 | 30 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 5.21e-05 | 7 | 30 | 2 | PF01030 | |
| Domain | Notch | 5.21e-05 | 7 | 30 | 2 | PF00066 | |
| Domain | - | 5.21e-05 | 7 | 30 | 2 | 3.80.20.20 | |
| Domain | NL | 5.21e-05 | 7 | 30 | 2 | SM00004 | |
| Domain | LAMININ_IVA | 6.94e-05 | 8 | 30 | 2 | PS51115 | |
| Domain | Laminin_B | 6.94e-05 | 8 | 30 | 2 | PF00052 | |
| Domain | LamB | 6.94e-05 | 8 | 30 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.94e-05 | 8 | 30 | 2 | IPR000034 | |
| Domain | NC1_FIB | 1.36e-04 | 11 | 30 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 1.36e-04 | 11 | 30 | 2 | PD002078 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | SM00038 | |
| Domain | COLFI | 1.36e-04 | 11 | 30 | 2 | PF01410 | |
| Domain | Unchr_dom_Cys-rich | 1.92e-04 | 13 | 30 | 2 | IPR014853 | |
| Domain | C8 | 1.92e-04 | 13 | 30 | 2 | SM00832 | |
| Domain | TIL_dom | 2.24e-04 | 14 | 30 | 2 | IPR002919 | |
| Domain | VWFD | 2.95e-04 | 16 | 30 | 2 | PS51233 | |
| Domain | VWD | 2.95e-04 | 16 | 30 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.95e-04 | 16 | 30 | 2 | IPR001846 | |
| Domain | VWD | 2.95e-04 | 16 | 30 | 2 | PF00094 | |
| Domain | Furin_repeat | 3.76e-04 | 18 | 30 | 2 | IPR006212 | |
| Domain | FU | 3.76e-04 | 18 | 30 | 2 | SM00261 | |
| Domain | cEGF | 7.91e-04 | 26 | 30 | 2 | IPR026823 | |
| Domain | cEGF | 7.91e-04 | 26 | 30 | 2 | PF12662 | |
| Domain | hEGF | 9.19e-04 | 28 | 30 | 2 | PF12661 | |
| Domain | LAM_G_DOMAIN | 1.69e-03 | 38 | 30 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 1.87e-03 | 40 | 30 | 2 | PF02210 | |
| Domain | LamG | 2.26e-03 | 44 | 30 | 2 | SM00282 | |
| Domain | Laminin_G | 3.90e-03 | 58 | 30 | 2 | IPR001791 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.09e-11 | 76 | 21 | 7 | M27219 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.29e-10 | 66 | 21 | 6 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.11e-10 | 30 | 21 | 5 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.18e-09 | 41 | 21 | 5 | M27778 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.13e-09 | 300 | 21 | 8 | M610 | |
| Pathway | KEGG_FOCAL_ADHESION | 9.89e-09 | 199 | 21 | 7 | M7253 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.09e-08 | 59 | 21 | 5 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.22e-08 | 79 | 21 | 5 | M27643 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.72e-08 | 30 | 21 | 4 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.72e-08 | 30 | 21 | 4 | MM15812 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.26e-07 | 84 | 21 | 5 | M7098 | |
| Pathway | WP_FOCAL_ADHESION | 2.31e-07 | 187 | 21 | 6 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 3.34e-07 | 199 | 21 | 6 | M39402 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.67e-07 | 11 | 21 | 3 | M158 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 5.70e-07 | 46 | 21 | 4 | M239 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.47e-06 | 66 | 21 | 4 | MM15925 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.81e-06 | 302 | 21 | 6 | M39719 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.35e-06 | 76 | 21 | 4 | MM14867 | |
| Pathway | WP_CANCER_PATHWAYS | 5.60e-06 | 507 | 21 | 7 | M48302 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 5.91e-06 | 326 | 21 | 6 | MM15917 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.81e-06 | 85 | 21 | 4 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.68e-06 | 532 | 21 | 7 | M27870 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.13e-05 | 30 | 21 | 3 | M27216 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.51e-05 | 33 | 21 | 3 | M39503 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.11e-05 | 5 | 21 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.11e-05 | 5 | 21 | 2 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 3.16e-05 | 6 | 21 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 4.42e-05 | 7 | 21 | 2 | MM14734 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.89e-05 | 140 | 21 | 4 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.31e-05 | 143 | 21 | 4 | M27275 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 7.09e-05 | 154 | 21 | 4 | M39739 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 9.48e-05 | 325 | 21 | 5 | M12868 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.70e-05 | 61 | 21 | 3 | M27103 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.15e-04 | 11 | 21 | 2 | M47865 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.16e-04 | 339 | 21 | 5 | M39736 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.34e-04 | 68 | 21 | 3 | M27303 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.38e-04 | 12 | 21 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.38e-04 | 12 | 21 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.63e-04 | 13 | 21 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.63e-04 | 13 | 21 | 2 | M47534 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.73e-04 | 74 | 21 | 3 | M160 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.19e-04 | 15 | 21 | 2 | M27161 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.50e-04 | 16 | 21 | 2 | M47424 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.51e-04 | 84 | 21 | 3 | M3228 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.08e-04 | 90 | 21 | 3 | M631 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 3.19e-04 | 18 | 21 | 2 | M39421 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.19e-04 | 18 | 21 | 2 | M614 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.56e-04 | 19 | 21 | 2 | M27221 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.56e-04 | 19 | 21 | 2 | MM15512 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.72e-04 | 96 | 21 | 3 | M39834 | |
| Pathway | WP_BURN_WOUND_HEALING | 4.36e-04 | 21 | 21 | 2 | MM15978 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.56e-04 | 250 | 21 | 4 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.13e-04 | 258 | 21 | 4 | MM14572 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.25e-04 | 23 | 21 | 2 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.72e-04 | 24 | 21 | 2 | M11190 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.16e-04 | 114 | 21 | 3 | MM14571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 6.21e-04 | 25 | 21 | 2 | M47934 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 6.98e-04 | 119 | 21 | 3 | M607 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.25e-04 | 27 | 21 | 2 | M39545 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 7.25e-04 | 27 | 21 | 2 | M27217 | |
| Pathway | WP_IL19_SIGNALING | 7.81e-04 | 28 | 21 | 2 | M48111 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.81e-04 | 28 | 21 | 2 | M6177 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 7.81e-04 | 28 | 21 | 2 | MM15957 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.97e-04 | 30 | 21 | 2 | MM15517 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 9.58e-04 | 31 | 21 | 2 | MM1343 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 9.58e-04 | 31 | 21 | 2 | MM15818 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.02e-03 | 32 | 21 | 2 | MM14924 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.02e-03 | 32 | 21 | 2 | M165 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.09e-03 | 33 | 21 | 2 | M240 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 1.15e-03 | 34 | 21 | 2 | M39390 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 1.29e-03 | 36 | 21 | 2 | M39569 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.36e-03 | 37 | 21 | 2 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.52e-03 | 39 | 21 | 2 | MM14604 | |
| Pathway | WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA | 1.59e-03 | 40 | 21 | 2 | M48337 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 1.67e-03 | 41 | 21 | 2 | M29748 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.67e-03 | 41 | 21 | 2 | MM15538 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.84e-03 | 43 | 21 | 2 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.84e-03 | 43 | 21 | 2 | M53 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.93e-03 | 44 | 21 | 2 | M27812 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.01e-03 | 45 | 21 | 2 | M39571 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.10e-03 | 46 | 21 | 2 | M198 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.10e-03 | 46 | 21 | 2 | MM15971 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.19e-03 | 47 | 21 | 2 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.19e-03 | 47 | 21 | 2 | M7946 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.48e-03 | 50 | 21 | 2 | M48087 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.48e-03 | 50 | 21 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.78e-03 | 53 | 21 | 2 | MM14566 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.96e-03 | 1387 | 21 | 7 | M734 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.05e-03 | 418 | 21 | 4 | MM15587 | |
| Pathway | PID_NOTCH_PATHWAY | 3.44e-03 | 59 | 21 | 2 | M17 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 3.64e-03 | 439 | 21 | 4 | M42563 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.67e-03 | 61 | 21 | 2 | M39540 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.67e-03 | 61 | 21 | 2 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.03e-03 | 64 | 21 | 2 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.41e-03 | 67 | 21 | 2 | M26999 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.41e-03 | 67 | 21 | 2 | MM15345 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 4.67e-03 | 69 | 21 | 2 | M48052 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 5.21e-03 | 73 | 21 | 2 | M638 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 5.35e-03 | 74 | 21 | 2 | M39857 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.53e-03 | 246 | 21 | 3 | M10189 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 5.50e-14 | 26 | 30 | 6 | 34189436 | |
| Pubmed | 2.86e-12 | 18 | 30 | 5 | 11311202 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL3A1 LRP4 DNAJC18 LAMB2 ERBB2 IGF1R FBN1 TNFRSF1A LUM CRIM1 NOTCH3 LAMA1 COL1A1 | 6.46e-12 | 1201 | 30 | 13 | 35696571 |
| Pubmed | 9.62e-11 | 167 | 30 | 7 | 22159717 | ||
| Pubmed | 1.34e-10 | 175 | 30 | 7 | 28071719 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.36e-09 | 18 | 30 | 4 | 39040056 | |
| Pubmed | 2.47e-09 | 64 | 30 | 5 | 22261194 | ||
| Pubmed | 2.70e-09 | 146 | 30 | 6 | 27068509 | ||
| Pubmed | 7.78e-09 | 27 | 30 | 4 | 35894043 | ||
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 17135260 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.05e-08 | 97 | 30 | 5 | 27559042 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 2.91e-08 | 37 | 30 | 4 | 34323105 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.37e-08 | 248 | 30 | 6 | 24006456 | |
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 9415455 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 30738849 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 9.51e-08 | 11 | 30 | 3 | 21524702 | |
| Pubmed | 1.01e-07 | 50 | 30 | 4 | 23658023 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.08e-07 | 135 | 30 | 5 | 28675934 | |
| Pubmed | 1.27e-07 | 12 | 30 | 3 | 9396756 | ||
| Pubmed | 1.65e-07 | 13 | 30 | 3 | 36350252 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 1.65e-07 | 13 | 30 | 3 | 20498044 | |
| Pubmed | 2.01e-07 | 153 | 30 | 5 | 25037231 | ||
| Pubmed | Defining brain wiring patterns and mechanisms through gene trapping in mice. | 2.09e-07 | 14 | 30 | 3 | 11242070 | |
| Pubmed | Loss of flow responsive Tie1 results in Impaired
Aortic valve remodeling. | 2.09e-07 | 14 | 30 | 3 | 31319059 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.62e-07 | 15 | 30 | 3 | 15895400 | |
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 17601529 | ||
| Pubmed | Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development. | 4.44e-07 | 72 | 30 | 4 | 37702066 | |
| Pubmed | 6.54e-07 | 20 | 30 | 3 | 22911573 | ||
| Pubmed | Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. | 7.19e-07 | 2 | 30 | 2 | 21743488 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27636223 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 7.19e-07 | 2 | 30 | 2 | 33665264 | |
| Pubmed | Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. | 7.19e-07 | 2 | 30 | 2 | 19560165 | |
| Pubmed | Collagen synthesis is not altered in women with stress urinary incontinence. | 7.19e-07 | 2 | 30 | 2 | 15227656 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29511113 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23040566 | ||
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 7.19e-07 | 2 | 30 | 2 | 17696940 | |
| Pubmed | Influence of fibrillin-1 genotype on aortic stiffness in men: a note of caution. | 7.19e-07 | 2 | 30 | 2 | 16540720 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23377784 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25432063 | ||
| Pubmed | Chromosomal position and activation of retroviral genomes inserted into the germ line of mice. | 7.19e-07 | 2 | 30 | 2 | 7237558 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27363273 | ||
| Pubmed | Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis. | 7.19e-07 | 2 | 30 | 2 | 34261485 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35587586 | ||
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 7.19e-07 | 2 | 30 | 2 | 11777956 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 3182802 | ||
| Pubmed | RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts. | 7.19e-07 | 2 | 30 | 2 | 17576241 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24227890 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18339869 | ||
| Pubmed | Collagen I and collagen III polymorphisms in women with pelvic organ prolapse. | 7.19e-07 | 2 | 30 | 2 | 32692893 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16521042 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 7.19e-07 | 2 | 30 | 2 | 32616814 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 3467899 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21447712 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25658374 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18401458 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21862872 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20015075 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17761519 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8851045 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23344861 | ||
| Pubmed | Altered procollagen gene expression in mid-gestational mouse excisional wounds. | 7.19e-07 | 2 | 30 | 2 | 17950069 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8601594 | ||
| Pubmed | 8.82e-07 | 22 | 30 | 3 | 27527664 | ||
| Pubmed | 8.82e-07 | 22 | 30 | 3 | 21979435 | ||
| Pubmed | 1.49e-06 | 26 | 30 | 3 | 24742657 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.73e-06 | 101 | 30 | 4 | 20551380 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.73e-06 | 101 | 30 | 4 | 23382219 | |
| Pubmed | 2.08e-06 | 29 | 30 | 3 | 22613833 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.14e-06 | 247 | 30 | 5 | 39238192 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24206174 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24655723 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24571711 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20704113 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 2.16e-06 | 3 | 30 | 2 | 25846406 | |
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 2.16e-06 | 3 | 30 | 2 | 17453912 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15022335 | ||
| Pubmed | Adenosine A2A receptor (A2AR) is a fine-tune regulator of the collagen1:collagen3 balance. | 2.16e-06 | 3 | 30 | 2 | 23749290 | |
| Pubmed | The EGF receptor interacts with the type 1 IGF receptor and regulates its stability. | 2.16e-06 | 3 | 30 | 2 | 17307140 | |
| Pubmed | Marfan-like skeletal phenotype in the tight skin (Tsk) mouse. | 2.16e-06 | 3 | 30 | 2 | 17705049 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20103628 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10620696 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25086405 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 28498399 | ||
| Pubmed | Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. | 2.16e-06 | 3 | 30 | 2 | 15645445 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 30273997 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 17662583 | ||
| Pubmed | TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. | 2.16e-06 | 3 | 30 | 2 | 17884256 | |
| Pubmed | Lack of endothelial cell apoptosis in the dermis of tight skin 1 and tight skin 2 mice. | 2.16e-06 | 3 | 30 | 2 | 10088787 | |
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 2.16e-06 | 3 | 30 | 2 | 24088220 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27870967 | ||
| Pubmed | Laminin-121--recombinant expression and interactions with integrins. | 2.16e-06 | 3 | 30 | 2 | 20566382 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 29543232 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 34205850 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 9614124 | ||
| Pubmed | Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. | 2.16e-06 | 3 | 30 | 2 | 7919967 | |
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 2.16e-06 | 3 | 30 | 2 | 8785585 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18483367 | ||
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 2.16e-06 | 3 | 30 | 2 | 1879336 | |
| Pubmed | Processing of procollagen III by meprins: new players in extracellular matrix assembly? | 2.16e-06 | 3 | 30 | 2 | 20631730 | |
| Interaction | IGFL3 interactions | 6.91e-08 | 75 | 29 | 5 | int:IGFL3 | |
| Interaction | NTN5 interactions | 5.31e-06 | 24 | 29 | 3 | int:NTN5 | |
| Interaction | COL7A1 interactions | 6.03e-06 | 25 | 29 | 3 | int:COL7A1 | |
| Interaction | OS9 interactions | 1.39e-05 | 219 | 29 | 5 | int:OS9 | |
| Interaction | FBXO2 interactions | 2.21e-05 | 411 | 29 | 6 | int:FBXO2 | |
| Interaction | TIMP2 interactions | 4.29e-05 | 277 | 29 | 5 | int:TIMP2 | |
| Interaction | SLC39A1 interactions | 4.44e-05 | 48 | 29 | 3 | int:SLC39A1 | |
| Interaction | MYOC interactions | 4.44e-05 | 48 | 29 | 3 | int:MYOC | |
| Interaction | ZNF408 interactions | 5.31e-05 | 145 | 29 | 4 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 7.44e-05 | 57 | 29 | 3 | int:ZFP41 | |
| Interaction | HYOU1 interactions | 8.13e-05 | 317 | 29 | 5 | int:HYOU1 | |
| Interaction | ZNF563 interactions | 1.31e-04 | 12 | 29 | 2 | int:ZNF563 | |
| Interaction | ZNF248 interactions | 1.54e-04 | 13 | 29 | 2 | int:ZNF248 | |
| Interaction | IGSF5 interactions | 1.80e-04 | 14 | 29 | 2 | int:IGSF5 | |
| Interaction | CDKN2B interactions | 1.82e-04 | 77 | 29 | 3 | int:CDKN2B | |
| Interaction | EGFL7 interactions | 1.82e-04 | 77 | 29 | 3 | int:EGFL7 | |
| Interaction | COL1A2 interactions | 1.90e-04 | 78 | 29 | 3 | int:COL1A2 | |
| Interaction | ST14 interactions | 2.10e-04 | 207 | 29 | 4 | int:ST14 | |
| Interaction | FGF7 interactions | 2.37e-04 | 16 | 29 | 2 | int:FGF7 | |
| Interaction | CLCN6 interactions | 2.37e-04 | 16 | 29 | 2 | int:CLCN6 | |
| Interaction | ITGB1 interactions | 2.41e-04 | 400 | 29 | 5 | int:ITGB1 | |
| Interaction | NID2 interactions | 2.53e-04 | 86 | 29 | 3 | int:NID2 | |
| Interaction | MAML2 interactions | 2.68e-04 | 17 | 29 | 2 | int:MAML2 | |
| Interaction | MPZL2 interactions | 3.02e-04 | 18 | 29 | 2 | int:MPZL2 | |
| Interaction | PIK3R2 interactions | 3.14e-04 | 230 | 29 | 4 | int:PIK3R2 | |
| Interaction | MAML3 interactions | 3.74e-04 | 20 | 29 | 2 | int:MAML3 | |
| Interaction | ZNF224 interactions | 3.74e-04 | 20 | 29 | 2 | int:ZNF224 | |
| Interaction | DEFA1 interactions | 3.94e-04 | 100 | 29 | 3 | int:DEFA1 | |
| Interaction | NOTCH4 interactions | 4.13e-04 | 21 | 29 | 2 | int:NOTCH4 | |
| Interaction | JAK1 interactions | 4.17e-04 | 248 | 29 | 4 | int:JAK1 | |
| Interaction | PLG interactions | 4.68e-04 | 106 | 29 | 3 | int:PLG | |
| Interaction | TTYH2 interactions | 4.96e-04 | 23 | 29 | 2 | int:TTYH2 | |
| Interaction | ATXN7 interactions | 5.08e-04 | 109 | 29 | 3 | int:ATXN7 | |
| Interaction | ILKAP interactions | 5.21e-04 | 110 | 29 | 3 | int:ILKAP | |
| Interaction | DUSP18 interactions | 5.41e-04 | 24 | 29 | 2 | int:DUSP18 | |
| Interaction | MEP1A interactions | 5.41e-04 | 24 | 29 | 2 | int:MEP1A | |
| Interaction | NAT2 interactions | 5.88e-04 | 25 | 29 | 2 | int:NAT2 | |
| Interaction | LAMA5 interactions | 6.24e-04 | 117 | 29 | 3 | int:LAMA5 | |
| Interaction | CYP17A1 interactions | 6.36e-04 | 26 | 29 | 2 | int:CYP17A1 | |
| Interaction | APBB3 interactions | 6.86e-04 | 27 | 29 | 2 | int:APBB3 | |
| Interaction | CXCL5 interactions | 6.86e-04 | 27 | 29 | 2 | int:CXCL5 | |
| Interaction | EFEMP1 interactions | 7.22e-04 | 123 | 29 | 3 | int:EFEMP1 | |
| Interaction | SMDT1 interactions | 7.38e-04 | 28 | 29 | 2 | int:SMDT1 | |
| Interaction | LTA interactions | 7.38e-04 | 28 | 29 | 2 | int:LTA | |
| Interaction | SLAMF1 interactions | 7.57e-04 | 125 | 29 | 3 | int:SLAMF1 | |
| Cytoband | 15q26.3 | 3.33e-04 | 41 | 30 | 2 | 15q26.3 | |
| GeneFamily | Laminin subunits | 3.93e-07 | 12 | 23 | 3 | 626 | |
| GeneFamily | UPF1 like RNA helicases | 8.45e-05 | 11 | 23 | 2 | 1169 | |
| GeneFamily | Collagens | 1.55e-03 | 46 | 23 | 2 | 490 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.32e-02 | 394 | 23 | 3 | 471 | |
| Coexpression | NABA_CORE_MATRISOME | 1.35e-11 | 270 | 30 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.59e-11 | 275 | 30 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | MEP1A COL3A1 VWC2L KCP LAMA3 LAMB2 HABP2 FBN1 LUM CRIM1 MUC6 LAMA1 COL1A1 | 2.43e-11 | 1008 | 30 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | MEP1A COL3A1 VWC2L KCP LAMA3 LAMB2 HABP2 FBN1 LUM CRIM1 MUC6 LAMA1 COL1A1 | 3.03e-11 | 1026 | 30 | 13 | M5889 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.59e-11 | 23 | 30 | 5 | M48001 | |
| Coexpression | JONES_OVARY_NK_CELL | 7.18e-10 | 89 | 30 | 6 | M48353 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.70e-08 | 6 | 30 | 3 | M48000 | |
| Coexpression | ZHU_CMV_24_HR_DN | 4.01e-08 | 84 | 30 | 5 | M4065 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.10e-08 | 191 | 30 | 6 | MM17059 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 7.12e-08 | 35 | 30 | 4 | MM17054 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.28e-08 | 196 | 30 | 6 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 9.33e-08 | 200 | 30 | 6 | M5930 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.13e-07 | 385 | 30 | 7 | M39264 | |
| Coexpression | ZHU_CMV_ALL_DN | 2.31e-07 | 119 | 30 | 5 | M14555 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.40e-07 | 47 | 30 | 4 | M7585 | |
| Coexpression | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP | 2.51e-07 | 121 | 30 | 5 | M8475 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.09e-07 | 50 | 30 | 4 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.63e-07 | 52 | 30 | 4 | MM1118 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 8.44e-07 | 64 | 30 | 4 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 8.99e-07 | 65 | 30 | 4 | M39309 | |
| Coexpression | MA_RAT_AGING_DN | 1.03e-06 | 161 | 30 | 5 | M46419 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.31e-06 | 505 | 30 | 7 | M39167 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN | 1.35e-06 | 170 | 30 | 5 | M8689 | |
| Coexpression | MA_RAT_AGING_DN | 1.35e-06 | 170 | 30 | 5 | MM16097 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.57e-06 | 324 | 30 | 6 | MM3701 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.71e-06 | 767 | 30 | 8 | M39209 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.77e-06 | 86 | 30 | 4 | M2259 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 3.15e-06 | 202 | 30 | 5 | M38982 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.48e-06 | 91 | 30 | 4 | M40180 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 3.88e-06 | 27 | 30 | 3 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 3.88e-06 | 27 | 30 | 3 | MM1135 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.85e-06 | 29 | 30 | 3 | MM17055 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 5.48e-06 | 102 | 30 | 4 | MM1064 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 8.64e-06 | 35 | 30 | 3 | M16637 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.04e-05 | 120 | 30 | 4 | M42505 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 1.23e-05 | 125 | 30 | 4 | M38988 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.30e-05 | 40 | 30 | 3 | M5887 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 1.65e-05 | 284 | 30 | 5 | M16975 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.76e-05 | 137 | 30 | 4 | M40313 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 2.01e-05 | 296 | 30 | 5 | M41675 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.14e-05 | 144 | 30 | 4 | M5942 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.26e-05 | 146 | 30 | 4 | M40222 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.54e-05 | 795 | 30 | 7 | M39050 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 4.00e-05 | 58 | 30 | 3 | M178 | |
| Coexpression | JONES_OVARY_PERICYTE | 4.29e-05 | 172 | 30 | 4 | M48351 | |
| Coexpression | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP | 4.66e-05 | 61 | 30 | 3 | M1192 | |
| Coexpression | OSAWA_TNF_TARGETS | 5.67e-05 | 10 | 30 | 2 | M15412 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 6.59e-05 | 192 | 30 | 4 | M42501 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.74e-05 | 69 | 30 | 3 | M10165 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 6.86e-05 | 194 | 30 | 4 | M39122 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 7.65e-05 | 72 | 30 | 3 | M9908 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP | 7.72e-05 | 200 | 30 | 4 | M5280 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 7.72e-05 | 200 | 30 | 4 | M5730 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 8.30e-05 | 74 | 30 | 3 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 8.30e-05 | 74 | 30 | 3 | M13547 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 8.64e-05 | 75 | 30 | 3 | MM1084 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 9.49e-05 | 211 | 30 | 4 | M12225 | |
| Coexpression | FRIDMAN_SENESCENCE_DN | 9.80e-05 | 13 | 30 | 2 | M9487 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.01e-04 | 79 | 30 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.05e-04 | 80 | 30 | 3 | MM1285 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 1.13e-04 | 82 | 30 | 3 | M39274 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 1.20e-04 | 224 | 30 | 4 | M9893 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.49e-04 | 90 | 30 | 3 | M38984 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.50e-04 | 16 | 30 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.50e-04 | 16 | 30 | 2 | MM1296 | |
| Coexpression | DEMAGALHAES_AGING_DN | 1.50e-04 | 16 | 30 | 2 | M2145 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 1.51e-04 | 238 | 30 | 4 | M12004 | |
| Coexpression | JONES_OVARY_T_CELL | 1.54e-04 | 91 | 30 | 3 | M48354 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 1.69e-04 | 94 | 30 | 3 | M7013 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.92e-04 | 18 | 30 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 1.92e-04 | 18 | 30 | 2 | MM1241 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.97e-04 | 99 | 30 | 3 | M39152 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 1.97e-04 | 99 | 30 | 3 | M40255 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.14e-04 | 19 | 30 | 2 | M15125 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.15e-04 | 261 | 30 | 4 | M1834 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 2.34e-04 | 267 | 30 | 4 | M6100 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.38e-04 | 20 | 30 | 2 | MM17053 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.66e-04 | 276 | 30 | 4 | M3063 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON | 2.88e-04 | 22 | 30 | 2 | M1352 | |
| Coexpression | DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 2.88e-04 | 22 | 30 | 2 | M34033 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 3.16e-04 | 289 | 30 | 4 | M41750 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.22e-04 | 117 | 30 | 3 | M39300 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 3.63e-04 | 548 | 30 | 5 | M16859 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 3.78e-04 | 303 | 30 | 4 | M39040 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.00e-04 | 126 | 30 | 3 | M39132 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 4.13e-04 | 310 | 30 | 4 | MM16608 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 4.19e-04 | 128 | 30 | 3 | M1966 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 4.28e-04 | 313 | 30 | 4 | M39128 | |
| Coexpression | RB_P107_DN.V1_UP | 4.39e-04 | 130 | 30 | 3 | M2802 | |
| Coexpression | SENESE_HDAC2_TARGETS_DN | 4.69e-04 | 133 | 30 | 3 | M6906 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 5.04e-04 | 29 | 30 | 2 | M7581 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 5.28e-04 | 595 | 30 | 5 | M40167 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.56e-04 | 141 | 30 | 3 | M10381 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 5.65e-04 | 337 | 30 | 4 | M13206 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 5.68e-04 | 142 | 30 | 3 | MM840 | |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 5.77e-04 | 31 | 30 | 2 | M3732 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 5.77e-04 | 31 | 30 | 2 | M18395 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 5.91e-04 | 144 | 30 | 3 | M1484 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 6.16e-04 | 146 | 30 | 3 | MM973 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 6.40e-04 | 148 | 30 | 3 | MM1010 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.20e-07 | 85 | 30 | 5 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.56e-06 | 453 | 30 | 7 | GSM777067_500 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 2.78e-06 | 70 | 30 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 2.84e-06 | 905 | 30 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 3.11e-06 | 72 | 30 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 6.64e-06 | 87 | 30 | 4 | GSM777050_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 9.58e-06 | 206 | 30 | 5 | JC_fibro_500_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.02e-05 | 97 | 30 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.02e-05 | 97 | 30 | 4 | GSM777046_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.53e-05 | 122 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.22e-05 | 265 | 30 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.59e-05 | 455 | 30 | 6 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 3.64e-05 | 456 | 30 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.11e-05 | 466 | 30 | 6 | GSM777050_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500 | 4.49e-05 | 49 | 30 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.87e-05 | 497 | 30 | 6 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 6.01e-05 | 54 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 6.62e-05 | 156 | 30 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.78e-05 | 310 | 30 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 8.23e-05 | 165 | 30 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 8.74e-05 | 783 | 30 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 8.74e-05 | 783 | 30 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.54e-05 | 63 | 30 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.91e-05 | 336 | 30 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.03e-04 | 1094 | 30 | 8 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 1.05e-04 | 65 | 30 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.10e-04 | 66 | 30 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.10e-04 | 66 | 30 | 3 | BM Top 100 - endometrium | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.18e-04 | 181 | 30 | 4 | gudmap_developingGonad_e14.5_ testes_1000_k2 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 1.20e-04 | 68 | 30 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.20e-04 | 182 | 30 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | BM Top 100 - stomach pyloric | 1.25e-04 | 69 | 30 | 3 | BM Top 100 - stomach pyloric | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.25e-04 | 69 | 30 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - ovary | 1.31e-04 | 70 | 30 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 1.36e-04 | 71 | 30 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | 1.39e-04 | 1143 | 30 | 8 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 1.42e-04 | 72 | 30 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.48e-04 | 73 | 30 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 1.54e-04 | 74 | 30 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 1.54e-04 | 74 | 30 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - urethra | 1.73e-04 | 77 | 30 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.97e-04 | 207 | 30 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_500 | 2.06e-04 | 393 | 30 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 2.09e-04 | 82 | 30 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | BM Top 100 - vulva | 2.09e-04 | 82 | 30 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 2.24e-04 | 84 | 30 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.41e-04 | 86 | 30 | 3 | GSM777055_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.45e-04 | 408 | 30 | 5 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.90e-04 | 229 | 30 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.91e-04 | 951 | 30 | 7 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.22e-04 | 433 | 30 | 5 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 3.23e-04 | 95 | 30 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.36e-04 | 437 | 30 | 5 | GSM777046_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 3.46e-04 | 240 | 30 | 4 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 3.54e-04 | 98 | 30 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 3.63e-04 | 986 | 30 | 7 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 3.65e-04 | 445 | 30 | 5 | GSM777043_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 3.72e-04 | 990 | 30 | 7 | JC_fibro_1000 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 4.09e-04 | 456 | 30 | 5 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 4.21e-04 | 459 | 30 | 5 | GSM777037_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.42e-04 | 464 | 30 | 5 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 5.09e-04 | 740 | 30 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 5.27e-04 | 1049 | 30 | 7 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 5.83e-04 | 493 | 30 | 5 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 5.88e-04 | 494 | 30 | 5 | JC_fibro_500 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 5.90e-04 | 761 | 30 | 6 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 5.94e-04 | 117 | 30 | 3 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 5.99e-04 | 496 | 30 | 5 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 6.55e-04 | 121 | 30 | 3 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 6.63e-04 | 778 | 30 | 6 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | 6.63e-04 | 778 | 30 | 6 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.20e-04 | 125 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_500 | 7.71e-04 | 128 | 30 | 3 | gudmap_developingGonad_e18.5_testes_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 8.07e-04 | 130 | 30 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 8.41e-04 | 814 | 30 | 6 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.41e-04 | 814 | 30 | 6 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.19e-04 | 136 | 30 | 3 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.01e-03 | 319 | 30 | 4 | gudmap_developingGonad_P2_testes_1000_k4 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000 | 1.03e-03 | 846 | 30 | 6 | gudmap_kidney_adult_CortVasc_Tie2_1000 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 1.05e-03 | 850 | 30 | 6 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_500 | 1.08e-03 | 144 | 30 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 1.08e-03 | 144 | 30 | 3 | gudmap_developingGonad_e11.5_testes_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.13e-03 | 146 | 30 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.13e-03 | 146 | 30 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | gallbladder | 1.17e-03 | 148 | 30 | 3 | gallbladder | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 1.20e-03 | 872 | 30 | 6 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.22e-03 | 336 | 30 | 4 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.23e-03 | 337 | 30 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.24e-03 | 878 | 30 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 1.25e-03 | 37 | 30 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.48e-03 | 354 | 30 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 1.51e-03 | 356 | 30 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200 | 1.52e-03 | 162 | 30 | 3 | gudmap_developingKidney_e15.5_S-shaped body_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.52e-03 | 357 | 30 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.58e-03 | 164 | 30 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.59e-03 | 361 | 30 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.64e-03 | 364 | 30 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.69e-03 | 168 | 30 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.72e-03 | 369 | 30 | 4 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.90e-03 | 175 | 30 | 3 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.81e-10 | 159 | 30 | 6 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-09 | 195 | 30 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.89e-09 | 200 | 30 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.38e-09 | 92 | 30 | 5 | bbaf5a131f860198840e34843b7c841bcc98d9c4 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.38e-09 | 92 | 30 | 5 | e6aa2b8ca9235a7291ee41d976b886fec185835d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-08 | 152 | 30 | 5 | 3a1414ba6a4972698c3262a00b124428835c35cb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-08 | 152 | 30 | 5 | ee7855d76a49d07a032677a4dc83aa6116d50518 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.04e-08 | 168 | 30 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.87e-08 | 171 | 30 | 5 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-08 | 171 | 30 | 5 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.87e-08 | 171 | 30 | 5 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-07 | 172 | 30 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-07 | 174 | 30 | 5 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-07 | 174 | 30 | 5 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-07 | 174 | 30 | 5 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-07 | 177 | 30 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-07 | 177 | 30 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-07 | 177 | 30 | 5 | 599cf7f5b774e197a1b43c98e4b9a8c1a618f38a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-07 | 179 | 30 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 184 | 30 | 5 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 184 | 30 | 5 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 184 | 30 | 5 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 184 | 30 | 5 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-07 | 186 | 30 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 186 | 30 | 5 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-07 | 186 | 30 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | 90a1078b0303799fba5d2ca4fa12076fd75b78b1 | |
| ToppCell | Control-Fibroblasts-Pathological_FB|Control / group, cell type (main and fine annotations) | 1.54e-07 | 187 | 30 | 5 | b7280b8baa0fba9c2b4bff660c240ed96f6ff9b7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | 0f90bce2087aecfdbb377e6f46c6e468efbb6e28 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 187 | 30 | 5 | 76c957b2976d38adb45e07bcf96c689442e1fc20 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-07 | 188 | 30 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-07 | 189 | 30 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 190 | 30 | 5 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 190 | 30 | 5 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 190 | 30 | 5 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 191 | 30 | 5 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 191 | 30 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 191 | 30 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-07 | 192 | 30 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 192 | 30 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-07 | 192 | 30 | 5 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-07 | 192 | 30 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 192 | 30 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-07 | 192 | 30 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-07 | 192 | 30 | 5 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-07 | 192 | 30 | 5 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.76e-07 | 192 | 30 | 5 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-07 | 192 | 30 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-07 | 193 | 30 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 193 | 30 | 5 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-07 | 193 | 30 | 5 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 193 | 30 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-07 | 193 | 30 | 5 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-07 | 193 | 30 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 30 | 5 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-07 | 194 | 30 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 195 | 30 | 5 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.90e-07 | 195 | 30 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 195 | 30 | 5 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.90e-07 | 195 | 30 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-07 | 195 | 30 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-07 | 195 | 30 | 5 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 195 | 30 | 5 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 30 | 5 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-07 | 196 | 30 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-07 | 196 | 30 | 5 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 30 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-07 | 196 | 30 | 5 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-07 | 196 | 30 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-07 | 196 | 30 | 5 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-07 | 197 | 30 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-07 | 197 | 30 | 5 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-07 | 198 | 30 | 5 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-07 | 198 | 30 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-07 | 198 | 30 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-07 | 198 | 30 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-07 | 198 | 30 | 5 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-07 | 198 | 30 | 5 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-07 | 198 | 30 | 5 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-07 | 198 | 30 | 5 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-07 | 198 | 30 | 5 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.10e-07 | 199 | 30 | 5 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.10e-07 | 199 | 30 | 5 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.10e-07 | 199 | 30 | 5 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.10e-07 | 199 | 30 | 5 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-07 | 199 | 30 | 5 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.10e-07 | 199 | 30 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-07 | 199 | 30 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-07 | 199 | 30 | 5 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.10e-07 | 199 | 30 | 5 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.10e-07 | 199 | 30 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| Computational | Ovary genes. | 1.20e-06 | 368 | 18 | 7 | MODULE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.21e-06 | 50 | 18 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Adhesion molecules. | 2.70e-06 | 141 | 18 | 5 | MODULE_122 | |
| Computational | Neighborhood of CDH11 | 8.86e-06 | 25 | 18 | 3 | GNF2_CDH11 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.58e-05 | 384 | 18 | 6 | MODULE_2 | |
| Computational | ECM and collagens. | 2.64e-05 | 225 | 18 | 5 | MODULE_47 | |
| Computational | Neighborhood of PTX3 | 2.72e-05 | 36 | 18 | 3 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.36e-05 | 50 | 18 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Placenta genes. | 7.37e-05 | 463 | 18 | 6 | MODULE_38 | |
| Computational | Bone remodeling. | 9.27e-05 | 54 | 18 | 3 | MODULE_234 | |
| Computational | Developmental processes. | 1.70e-04 | 333 | 18 | 5 | MODULE_220 | |
| Computational | Spinal cord (neuro-development) genes. | 2.45e-04 | 360 | 18 | 5 | MODULE_12 | |
| Computational | Signaling. | 4.93e-04 | 230 | 18 | 4 | MODULE_176 | |
| Computational | Lung genes. | 5.81e-04 | 434 | 18 | 5 | MODULE_5 | |
| Computational | Genes in the cancer module 112. | 7.83e-04 | 260 | 18 | 4 | MODULE_112 | |
| Computational | Genes in the cancer module 153. | 1.44e-03 | 34 | 18 | 2 | MODULE_153 | |
| Computational | Genes in the cancer module 287. | 3.09e-03 | 50 | 18 | 2 | MODULE_287 | |
| Computational | Genes in the cancer module 105. | 4.21e-03 | 200 | 18 | 3 | MODULE_105 | |
| Computational | Trachea genes. | 4.36e-03 | 415 | 18 | 4 | MODULE_6 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.26e-11 | 83 | 30 | 7 | CID011968896 | |
| Drug | ALT-711 | 1.44e-08 | 21 | 30 | 4 | CID000216304 | |
| Drug | hyaluronan | 4.11e-08 | 263 | 30 | 7 | CID000024759 | |
| Drug | YIGSR | 5.89e-08 | 79 | 30 | 5 | CID000123977 | |
| Drug | Ikvav | 1.75e-07 | 38 | 30 | 4 | CID000131343 | |
| Drug | AC1L1G72 | 3.38e-07 | 11 | 30 | 3 | CID000003553 | |
| Drug | B-Ms | 3.71e-07 | 114 | 30 | 5 | CID000445091 | |
| Drug | dermatan sulfate | 3.72e-07 | 220 | 30 | 6 | CID000032756 | |
| Drug | colchine | 5.26e-07 | 383 | 30 | 7 | CID000002833 | |
| Drug | LG 5 | 1.13e-06 | 60 | 30 | 4 | CID011840957 | |
| Drug | isocycloheximide | 1.60e-06 | 905 | 30 | 9 | CID000002900 | |
| Drug | I-Q-S | 1.76e-06 | 156 | 30 | 5 | CID000003540 | |
| Drug | CCRIS 4306 | 2.70e-06 | 21 | 30 | 3 | CID011984829 | |
| Drug | A0395 | 2.79e-06 | 75 | 30 | 4 | CID009906466 | |
| Drug | 2-amino-5-methylpyridine | 3.10e-06 | 77 | 30 | 4 | CID000015348 | |
| Drug | diethyl maleate | 3.17e-06 | 318 | 30 | 6 | ctd:C014476 | |
| Drug | Sikvav | 4.10e-06 | 24 | 30 | 3 | CID005487517 | |
| Drug | Grgds | 4.19e-06 | 83 | 30 | 4 | CID000123811 | |
| Drug | NSC 714187 | 4.60e-06 | 85 | 30 | 4 | CID005288693 | |
| Drug | AC1L1B58 | 7.37e-06 | 29 | 30 | 3 | CID000001288 | |
| Drug | Collagenase | 1.01e-05 | 4 | 30 | 2 | DB00048 | |
| Drug | isodesmosine | 1.10e-05 | 33 | 30 | 3 | CID000013811 | |
| Drug | AC1L1C2F | 1.28e-05 | 110 | 30 | 4 | CID000001711 | |
| Drug | Rgd Peptide | 1.41e-05 | 239 | 30 | 5 | CID000104802 | |
| Drug | chondroitin sulfate | 1.41e-05 | 413 | 30 | 6 | CID000024766 | |
| Drug | Saralasin | 1.67e-05 | 5 | 30 | 2 | ctd:D012504 | |
| Drug | Calcort | 1.69e-05 | 38 | 30 | 3 | CID000026709 | |
| Drug | LMWH | 1.95e-05 | 663 | 30 | 7 | CID000000772 | |
| Drug | Linuron | 2.33e-05 | 128 | 30 | 4 | ctd:D008044 | |
| Drug | enzacamene | 2.40e-05 | 129 | 30 | 4 | ctd:C038939 | |
| Drug | quinaprilat | 2.46e-05 | 43 | 30 | 3 | CID000107994 | |
| Drug | BPAT-143 | 2.51e-05 | 6 | 30 | 2 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 2.51e-05 | 6 | 30 | 2 | ctd:C502971 | |
| Drug | NC-4 | 2.64e-05 | 44 | 30 | 3 | CID006420119 | |
| Drug | ammonium perchlorate | 3.51e-05 | 7 | 30 | 2 | ctd:C053506 | |
| Drug | secoisolariciresinol diglucoside | 3.51e-05 | 7 | 30 | 2 | ctd:C090142 | |
| Drug | desmosine | 4.63e-05 | 53 | 30 | 3 | CID000025435 | |
| Drug | HHMD | 4.68e-05 | 8 | 30 | 2 | CID000171068 | |
| Drug | Folfox protocol | 4.68e-05 | 8 | 30 | 2 | ctd:C410216 | |
| Drug | procymidone | 4.93e-05 | 155 | 30 | 4 | ctd:C035988 | |
| Drug | kalinin | 5.17e-05 | 55 | 30 | 3 | CID000032518 | |
| Drug | Ambroxol | 6.01e-05 | 9 | 30 | 2 | ctd:D000551 | |
| Drug | azelastine | 6.01e-05 | 9 | 30 | 2 | ctd:C020976 | |
| Drug | CC270 | 6.38e-05 | 59 | 30 | 3 | CID006918852 | |
| Drug | Mifepristone | 7.22e-05 | 553 | 30 | 6 | ctd:D015735 | |
| Drug | Dimethyl Sulfoxide | 7.25e-05 | 337 | 30 | 5 | ctd:D004121 | |
| Drug | AC1Q641C | 7.41e-05 | 62 | 30 | 3 | CID000005005 | |
| Drug | enterotoxin C, staphylococcal | 9.16e-05 | 11 | 30 | 2 | ctd:C034959 | |
| Drug | BM165 | 9.16e-05 | 11 | 30 | 2 | CID003352881 | |
| Drug | hematoxilina | 9.40e-05 | 183 | 30 | 4 | CID000010603 | |
| Drug | marimastat | 9.76e-05 | 68 | 30 | 3 | CID000119031 | |
| Drug | solamargine | 1.10e-04 | 12 | 30 | 2 | CID000073611 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 5582_UP | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 4540_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 3983_UP | |
| Drug | dysprosium | 1.26e-04 | 74 | 30 | 3 | CID000023912 | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 5064_UP | |
| Drug | Androgen Antagonists | 1.31e-04 | 75 | 30 | 3 | ctd:D000726 | |
| Drug | Griseofulvin | 1.41e-04 | 77 | 30 | 3 | ctd:D006118 | |
| Drug | N-acetyl-4-benzoquinoneimine | 1.41e-04 | 77 | 30 | 3 | ctd:C028473 | |
| Drug | 8-azaguanine | 1.47e-04 | 78 | 30 | 3 | CID000008646 | |
| Drug | Dhlnl | 1.51e-04 | 14 | 30 | 2 | CID000124011 | |
| Drug | inchinko-to | 1.51e-04 | 14 | 30 | 2 | ctd:C078038 | |
| Drug | ascorbate-2-phosphate | 1.74e-04 | 15 | 30 | 2 | ctd:C011669 | |
| Drug | Antineoplastic Agents | 1.74e-04 | 15 | 30 | 2 | ctd:D000970 | |
| Drug | DB07589 | 1.74e-04 | 15 | 30 | 2 | CID011840934 | |
| Drug | Galactosamine | 1.77e-04 | 83 | 30 | 3 | ctd:D005688 | |
| Drug | 1,2-dimethylhydrazine | 1.96e-04 | 86 | 30 | 3 | CID000001322 | |
| Drug | Sodium, Dietary | 1.99e-04 | 16 | 30 | 2 | ctd:D012982 | |
| Drug | glucosylgalactosylhydroxylysine | 1.99e-04 | 16 | 30 | 2 | CID000122304 | |
| Drug | sulfate | 2.00e-04 | 1292 | 30 | 8 | CID000001117 | |
| Drug | JP8 aviation fuel | 2.01e-04 | 419 | 30 | 5 | ctd:C098607 | |
| Drug | poly-N-acetyllactosamine | 2.10e-04 | 88 | 30 | 3 | CID000119547 | |
| Drug | H-9 dihydrochloride | 2.24e-04 | 90 | 30 | 3 | CID000003544 | |
| Drug | Lignans | 2.25e-04 | 17 | 30 | 2 | ctd:D017705 | |
| Drug | imatinib | 2.27e-04 | 430 | 30 | 5 | CID000005291 | |
| Drug | U0126 | 2.27e-04 | 430 | 30 | 5 | CID000005637 | |
| Drug | Betamethasone-d5 | 2.57e-04 | 1340 | 30 | 8 | CID000003003 | |
| Drug | BMS-186282 | 2.63e-04 | 95 | 30 | 3 | CID000002416 | |
| Drug | Linseed Oil | 2.83e-04 | 19 | 30 | 2 | ctd:D008043 | |
| Drug | Hlnl | 2.83e-04 | 19 | 30 | 2 | CID000122155 | |
| Drug | Nitrogen Mustard Compounds | 2.83e-04 | 19 | 30 | 2 | ctd:D009588 | |
| Drug | Paclitaxel | 3.04e-04 | 720 | 30 | 6 | ctd:D017239 | |
| Drug | 351A | 3.14e-04 | 20 | 30 | 2 | CID000122144 | |
| Drug | galactosylhydroxylysine | 3.14e-04 | 20 | 30 | 2 | CID000123986 | |
| Drug | NCI60_002052 | 3.14e-04 | 20 | 30 | 2 | CID006801032 | |
| Drug | Tungsten Compounds | 3.15e-04 | 101 | 30 | 3 | ctd:D017973 | |
| Drug | TAAD | 3.47e-04 | 21 | 30 | 2 | CID000133445 | |
| Drug | manidipine | 3.47e-04 | 21 | 30 | 2 | ctd:C054218 | |
| Drug | AC1L1KMJ | 3.62e-04 | 476 | 30 | 5 | CID000030956 | |
| Drug | Rgds Peptide | 3.63e-04 | 106 | 30 | 3 | CID000107775 | |
| Drug | Gdrgdsp | 3.94e-04 | 109 | 30 | 3 | CID000115346 | |
| Drug | prochloraz | 4.04e-04 | 268 | 30 | 4 | ctd:C045362 | |
| Drug | Capsaicin | 4.06e-04 | 488 | 30 | 5 | ctd:D002211 | |
| Drug | NSC19448 | 4.33e-04 | 273 | 30 | 4 | CID000003054 | |
| Drug | AC1L9732 | 4.50e-04 | 114 | 30 | 3 | CID000439300 | |
| Drug | Nbd-Ph | 4.55e-04 | 24 | 30 | 2 | CID004682184 | |
| Drug | dichloroboron | 4.94e-04 | 25 | 30 | 2 | CID000139621 | |
| Drug | ng h | 4.94e-04 | 25 | 30 | 2 | CID000448002 | |
| Drug | methylmercury II | 5.22e-04 | 120 | 30 | 3 | ctd:C030957 | |
| Disease | Familial aortopathy | 2.80e-06 | 3 | 29 | 2 | cv:CN078214 | |
| Disease | systemic scleroderma (implicated_via_orthology) | 2.80e-06 | 3 | 29 | 2 | DOID:418 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis | 3.11e-06 | 103 | 29 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 3.36e-06 | 105 | 29 | 4 | C0239946 | |
| Disease | Ehlers-Danlos Syndrome | 9.31e-06 | 5 | 29 | 2 | C0013720 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.18e-05 | 45 | 29 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | central corneal thickness | 1.18e-05 | 309 | 29 | 5 | EFO_0005213 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.27e-05 | 147 | 29 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.78e-05 | 160 | 29 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.93e-05 | 53 | 29 | 3 | C4707243 | |
| Disease | Ehlers-Danlos syndrome | 2.60e-05 | 8 | 29 | 2 | cv:C0013720 | |
| Disease | Malignant neoplasm of skin | 2.67e-05 | 59 | 29 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.67e-05 | 59 | 29 | 3 | C0037286 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 3.34e-05 | 9 | 29 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Nephrosclerosis | 5.10e-05 | 11 | 29 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 5.10e-05 | 11 | 29 | 2 | C0003504 | |
| Disease | dementia (is_implicated_in) | 6.12e-05 | 12 | 29 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 6.12e-05 | 12 | 29 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 7.23e-05 | 13 | 29 | 2 | C0238288 | |
| Disease | hypertrophic cardiomyopathy | 1.01e-04 | 92 | 29 | 3 | EFO_0000538 | |
| Disease | lupus nephritis (is_marker_for) | 1.26e-04 | 17 | 29 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | Myasthenic Syndromes, Congenital | 2.54e-04 | 24 | 29 | 2 | C0751882 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.54e-04 | 24 | 29 | 2 | C0887833 | |
| Disease | systemic scleroderma (is_implicated_in) | 2.54e-04 | 24 | 29 | 2 | DOID:418 (is_implicated_in) | |
| Disease | systolic blood pressure, alcohol drinking | 2.68e-04 | 128 | 29 | 3 | EFO_0004329, EFO_0006335 | |
| Disease | Left Ventricular Hypertrophy | 2.76e-04 | 25 | 29 | 2 | C0149721 | |
| Disease | Endogenous Hyperinsulinism | 2.99e-04 | 26 | 29 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.99e-04 | 26 | 29 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.99e-04 | 26 | 29 | 2 | C1257965 | |
| Disease | Hyperinsulinism | 3.47e-04 | 28 | 29 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 3.99e-04 | 30 | 29 | 2 | C1855520 | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 3.99e-04 | 30 | 29 | 2 | DOID:2986 (is_implicated_in) | |
| Disease | Hyperglycemia | 3.99e-04 | 30 | 29 | 2 | C0020456 | |
| Disease | osteoporosis (is_implicated_in) | 4.26e-04 | 31 | 29 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 4.54e-04 | 32 | 29 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Cholestasis, Extrahepatic | 4.54e-04 | 32 | 29 | 2 | C0005398 | |
| Disease | hyperuricemia | 4.83e-04 | 33 | 29 | 2 | EFO_0009104 | |
| Disease | nephroblastoma (is_marker_for) | 5.13e-04 | 34 | 29 | 2 | DOID:2154 (is_marker_for) | |
| Disease | Keloid | 5.44e-04 | 35 | 29 | 2 | C0022548 | |
| Disease | endometrial cancer (is_marker_for) | 5.44e-04 | 35 | 29 | 2 | DOID:1380 (is_marker_for) | |
| Disease | cortical thickness | 6.40e-04 | 1113 | 29 | 6 | EFO_0004840 | |
| Disease | ulcerative colitis (is_marker_for) | 7.11e-04 | 40 | 29 | 2 | DOID:8577 (is_marker_for) | |
| Disease | high grade glioma (is_implicated_in) | 7.84e-04 | 42 | 29 | 2 | DOID:3070 (is_implicated_in) | |
| Disease | Autoimmune Diseases | 7.84e-04 | 42 | 29 | 2 | C0004364 | |
| Disease | Hypertensive disease | 8.49e-04 | 190 | 29 | 3 | C0020538 | |
| Disease | end stage renal disease (is_marker_for) | 9.40e-04 | 46 | 29 | 2 | DOID:783 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPDEEGACQPCPINC | 616 | P04626 | |
| NGCCPDCKVPGDDCP | 31 | Q9NYG5 | |
| QPPNCEGEVCCPVFA | 371 | Q8NCT1 | |
| NADGQCVPPEECPCE | 816 | Q6W4X9 | |
| ECVPCNCNRDGTEPG | 1401 | Q16787 | |
| CIPCEGPCPKVCEEE | 321 | P08069 | |
| RCQQDVDECAGPAPC | 806 | Q9UM47 | |
| PCDCDVGGALDPQCD | 521 | P55268 | |
| PEAEDPDRGQPCNSC | 16 | O43900 | |
| EDQADPCQPNPCEHG | 71 | Q14520 | |
| CDDVNECETPGICGP | 1646 | P35555 | |
| VPEGECCPVCEDPVY | 381 | Q9NZV1 | |
| EPINVEGSCCPMCPE | 861 | Q9NZV1 | |
| GQSSPNCAPECNCPE | 31 | P51884 | |
| EEDPLPNCGACAPGQ | 26 | Q99705 | |
| EDTPPESHDPCGCCN | 26 | Q9H819 | |
| ELDCPNPEIPFGECC | 71 | P02461 | |
| NPEIPFGECCAVCPQ | 76 | P02461 | |
| NEDQELPCPLGPGEC | 181 | Q9HCE1 | |
| ADPCEVCICEPQPEG | 1036 | Q6ZWJ8 | |
| DEPCRPCNCDPVGSL | 391 | P25391 | |
| RDPCDPNPCQNDGIC | 671 | Q16819 | |
| CERDVNECFQDPGPC | 191 | Q99466 | |
| CPGAEVPEGECCPVC | 81 | P02452 | |
| CPADPLPCEELCDGD | 126 | Q8IUB2 | |
| CVPEGDALVCADPCQ | 161 | P07911 | |
| PCQDQCPPQCAEPCQ | 76 | Q5T870 | |
| VPCSVPESDFCCQEP | 1361 | Q9P2E3 | |
| QEPCIGECPPCQRTC | 1476 | Q9P2E3 | |
| ICPGEDPCQSAECEE | 96 | Q8TA94 | |
| ECVNPVYEPEQCCPV | 156 | B2RUY7 | |
| DCPGPGQDTDCRECE | 71 | P19438 | |
| PPRECEEDEFPCQNG | 106 | O75096 |